ScienceNew Pancreatic Cancer Pill Nearly Doubles Survival in 500-Patient TrialA once-daily pill called daraxonrasib pushed median survival from 6.7 to 13.2 months in advanced pancreatic cancer — the first real breakthrough in a disease long called "undruggable."
TechnologymRNA Cancer Vaccine Cuts Melanoma Recurrence by 49% After Five YearsNew five-year data from the KEYNOTE-942 trial shows Moderna's personalized mRNA vaccine intismeran, paired with Keytruda, nearly halves the risk of melanoma returning after surgery.
ScienceAsthma Drug Montelukast May Fight Aggressive Cancers, Study FindsNorthwestern researchers found that a common asthma medication can switch off the molecule tumors use to evade the immune system, restoring response to immunotherapy in tough cancers.
